Drug (ID: DG02144) and It's Reported Resistant Information
Name
Gemcitabine/Huaier
Synonyms
Gemcitabine/Huaier
    Click to Show/Hide
Indication
In total 1 Indication(s)
. .
.
[1]
Type(s) of Resistant Mechanism of This Drug
  ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Click to Show/Hide the Resistance Disease of This Class
Pancreatic cancer [ICD-11: 2C10]
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
  Aberration of the Drug's Therapeutic Target (ADTT) Click to Show/Hide
Key Molecule: Forkhead box protein M1 (FOXM1) [1]
Sensitive Disease Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0]
Molecule Alteration Expressiom
Up-regulation
Experimental Note Discovered Using In-vivo Testing Model
In Vivo Model nude mice injected Panc-1 cells Mus musculus
Experiment for
Drug Resistance
Tumor evaluation assay
Mechanism Description Overall, this study illustrates that Huaier augments the tumor-killing effect of gemcitabine through suppressing the stemness induced by gemcitabine in a FoxM1-dependent way. These results indicate that Huaier can be applied to overcome gemcitabine resistance.
References
Ref 1 Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1. Phytomedicine. 2024 Jul;129:155656.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.